Posted on 21/01/2010 in Medical Company Product News A Menarini Diagnostics revealed this week that it has established a new website, bringing the web bases of its European divisions up to 15.
Each of the sites has been designed to offer ease of use to visitors with language options and for the rapid and efficient access of information.
The group, which is a major name in the diagnostics market, has responded to the needs and requests of patients by introducing internet hubs that provide illustrative materials and advice on the correct use of glucometers among diabetes patients.
Healthcare professionals can also access a password-protected area via the company's sites, which saw 600,000 users in 2009.
"It is our mission to guarantee the highest degree of customer satisfaction through the delivery of top quality services and diagnostics products," explained Mauro Romanelli, director of the firm's Italian operations.
Meanwhile, A Menarini announced in October that Ipsen granted it the licence rights for its novel treatment for chronic hyperuricaemia in gout - Adenuric (febuxostat).Other news stories from 21/01/2010
Read more in the Zenopa News Archive
How this news is generated
|
